Mark S. Ordan's Insider Trades & SAST Disclosures
Mark S. Ordan's most recent trade in Pediatrix Medical Group Inc was a trade of 640,000 Performance Share Unit done . Disclosure was reported to the exchange on Jan. 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mark S. Ordan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2025 | 640,000 | 640,000 | - | - | Performance Share Unit | |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director | Sale of securities on an exchange or to another person at price $ 15.35 per share. | 13 Nov 2024 | 27,600 | 138,683 (0%) | 0% | 15.4 | 423,660 | Common Stock |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 18,360 | 166,283 (0%) | 0% | 0 | Common Stock | |
| Carlyle Group Inc (The) | Mark S. Ordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 5,004 | 16,478 (0%) | 0% | 0 | Common Stock | |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director | Sale of securities on an exchange or to another person at price $ 13.26 per share. | 25 May 2023 | 33,000 | 147,923 (0%) | 0% | 13.3 | 437,580 | Common Stock |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 9,463 | 180,923 (0%) | 0% | 0 | Common Stock | |
| Carlyle Group Inc (The) | Mark S. Ordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 6,238 | 11,474 (0%) | 0% | 0 | Common Stock | |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.86 per share. | 31 Dec 2022 | 98,932 | 247,713 (0%) | 0% | 14.9 | 1,470,130 | Common Stock |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.45 per share. | 21 Nov 2022 | 22,166 | 346,645 (0%) | 0% | 15.5 | 342,465 | Common Stock |
| Carlyle Group Inc (The) | Mark S. Ordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2022 | 5,236 | 5,236 (0%) | 0% | 0 | Common Stock | |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 76,253 | 313,249 (0%) | 0% | 0 | Common Stock | |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 76,253 | 389,502 (0%) | 0% | 0 | Common Stock | |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.47 per share. | 01 Mar 2022 | 20,691 | 368,811 (0%) | 0% | 23.5 | 485,618 | Common Stock |
| Federal Realty Investment ... | Mark S. Ordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 880 | 3,102 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.65 per share. | 30 Aug 2021 | 95,000 | 303,425 (0%) | 0% | 17.7 | 1,676,750 | Common Stock |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2021 | 95,000 | 455,331 | - | - | Employee Stock Option (right to buy) | |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 35.09 per share. | 30 Aug 2021 | 95,000 | 208,425 (0%) | 0% | 35.1 | 3,333,550 | Common Stock |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 71,429 | 136,996 (0%) | 0% | 0 | Common Stock | |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 71,429 | 208,425 (0%) | 0% | 0 | Common Stock | |
| Federal Realty Investment ... | Mark S. Ordan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 1,410 | 2,222 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2020 | 550,331 | 550,331 | - | - | Employee Stock Option (right to buy) | |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2020 | 113,314 | 113,314 (0%) | 0% | 0 | Common Stock | |
| Pediatrix Medical Group Inc | Mark S. Ordan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.65 per share. | 12 Jul 2020 | 47,747 | 65,567 (0%) | 0% | 17.7 | 842,735 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges